Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Stryker logo
StrykerSYK
$2.88B+24.1%
PDE
Pro-Dex, Inc.PDEX
$9.99M+123%
CONMED logo
CONMEDCNMD
$35.03M-1.3%
Vericel logo
VericelVCEL
$109.3M+37.1%
Anika Therapeutics logo
Anika TherapeuticsANIK
$41.02M-23.1%

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.61B-6.5%
Enterprise value$24.66B-4.6%
P/E23.1×+0.3×
P/S2.1×-0.3×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Reported directly by Zimmer Biomet Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's cash & equivalents?
Zimmer Biomet Holdings (ZBH) reported cash & equivalents of $424.2M in Q1 2026.
How has Zimmer Biomet Holdings's cash & equivalents changed year-over-year?
Zimmer Biomet Holdings's cash & equivalents decreased by 69.4% year-over-year, from $1.38B to $424.2M.
What is the long-term trend for Zimmer Biomet Holdings's cash & equivalents?
Over 5 years (2020 to 2025), Zimmer Biomet Holdings's cash & equivalents has grown at a -5.9% compound annual growth rate (CAGR), from $802.1M to $591.9M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.